Study Shows Effient Not Superior To Plavix, But Bleeding Risk Similar
This article was originally published in The Pink Sheet Daily
Executive Summary
A study published in the New England Journal of Medicine showed Effient was not superior to Plavix in treating patients who had not undergone revascularization.